Intranasal vaccines for SARS-CoV-2: From challenges to potential in COVID-19 management
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intranasal vaccines for SARS-CoV-2: From challenges to potential in COVID-19 management
Authors
Keywords
COVID-19, SARS-CoV-2, Nasal vaccine, Nasal spray, Antigen-presenting cells (APCs), Dendritic cells
Journal
DRUG DISCOVERY TODAY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-07-29
DOI
10.1016/j.drudis.2021.07.021
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nanocarrier Vaccines for SARS-CoV-2
- (2021) Jatin Machhi et al. ADVANCED DRUG DELIVERY REVIEWS
- A Role for Extracellular Vesicles in SARS-CoV-2 Therapeutics and Prevention
- (2021) Jatin Machhi et al. Journal of Neuroimmune Pharmacology
- Viral Vectors for COVID-19 Vaccine Development
- (2021) Kenneth Lundstrom Viruses-Basel
- COVID-19 vaccines: rapid development, implications, challenges and future prospects
- (2021) Shivaji Kashte et al. Human Cell
- Targets and strategies for vaccine development against SARS-CoV-2
- (2021) Jonaid Ahmad Malik et al. BIOMEDICINE & PHARMACOTHERAPY
- Low pH Hypromellose (Taffix) nasal powder spray could reduce SARS-CoV-2 infection rate post mass-gathering event at a highly endemic community: an observational prospective open label user survey
- (2021) Klang Shmuel et al. Expert Review of Anti-Infective Therapy
- Inhaled vaccine delivery in the combat against respiratory viruses: a 2021 overview of recent developments and implications for COVID-19.
- (2021) Rick Heida et al. Expert Review of Vaccines
- Non-invasive mucosal vaccine delivery: advantages, challenges and the future
- (2020) Mariusz Skwarczynski et al. Expert Opinion on Drug Delivery
- The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak
- (2020) Hussin A. Rothan et al. JOURNAL OF AUTOIMMUNITY
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses
- (2020) Ning Wang et al. Frontiers in Microbiology
- Ebola virus disease
- (2020) Shevin T. Jacob et al. Nature Reviews Disease Primers
- Structural basis for RNA replication by the SARS-CoV-2 polymerase
- (2020) Quan Wang et al. CELL
- The establishment of reference sequence for SARS‐CoV‐2 and variation analysis
- (2020) Changtai Wang et al. JOURNAL OF MEDICAL VIROLOGY
- Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
- (2020) Jun Lan et al. NATURE
- Cytokine release syndrome in severe COVID-19
- (2020) John B. Moore et al. SCIENCE
- Consensus Summary Report for CEPI/BC March 12-13, 2020 Meeting: Assessment of Risk of Disease Enhancement with COVID-19 Vaccines
- (2020) Paul-Henri Lambert et al. VACCINE
- A Novel Synonymous Mutation of SARS-CoV-2: Is This Possible to Affect Their Antigenicity and Immunogenicity?
- (2020) Sung-Jae Kim et al. Vaccines
- Urgent Appeal from International Society for Aerosols in Medicine (ISAM) During COVID-19: Clinical Decision Makers and Governmental Agencies Should Consider the Inhaled Route of Administration: A Statement from the ISAM Regulatory and Standardization Issues Networking Group
- (2020) Jolyon P. Mitchell et al. Journal of Aerosol Medicine and Pulmonary Drug Delivery
- A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2
- (2020) Ahmed O. Hassan et al. CELL
- Pros and Cons of Adenovirus-Based SARS-CoV-2 Vaccines
- (2020) Eric J. Kremer MOLECULAR THERAPY
- SARS-CoV-2 vaccines in development
- (2020) Florian Krammer NATURE
- COVID-19 pandemic: Insights into structure, function, and hACE2 receptor recognition by SARS-CoV-2
- (2020) Anshumali Mittal et al. PLoS Pathogens
- COVID-19 Vaccines May Not Prevent Nasal SARS-CoV-2 Infection and Asymptomatic Transmission
- (2020) Benjamin S. Bleier et al. OTOLARYNGOLOGY-HEAD AND NECK SURGERY
- IgA dominates the early neutralizing antibody response to SARS-CoV-2
- (2020) Delphine Sterlin et al. Science Translational Medicine
- Development of novel vaccine vectors: Chimpanzee adenoviral vectors
- (2018) Jingao Guo et al. Human Vaccines & Immunotherapeutics
- The fear of needles: A systematic review and meta-analysis
- (2018) Jennifer McLenon et al. JOURNAL OF ADVANCED NURSING
- Non-inferiority of nitric oxide releasing intranasal spray compared to sub-therapeutic antibiotics to reduce incidence of undifferentiated fever and bovine respiratory disease complex in low to moderate risk beef cattle arriving at a commercial feedlot
- (2017) G. Regev-Shoshani et al. PREVENTIVE VETERINARY MEDICINE
- Current prospects and future challenges for nasal vaccine delivery
- (2016) Helmy Yusuf et al. Human Vaccines & Immunotherapeutics
- Methods and clinical development of adenovirus-vectored vaccines against mucosal pathogens
- (2016) Sam Afkhami et al. Molecular Therapy-Methods & Clinical Development
- Novel Insights into Interleukin 6 (IL-6) Cis- and Trans-signaling Pathways by Differentially Manipulating the Assembly of the IL-6 Signaling Complex
- (2015) Marine Lacroix et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Generation of Th17 cells in response to intranasal infection requires TGF-β1 from dendritic cells and IL-6 from CD301b+dendritic cells
- (2015) Jonathan L. Linehan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Intranasal and oral vaccination with protein-based antigens: advantages, challenges and formulation strategies
- (2015) Shujing Wang et al. Protein & Cell
- Effect of an Acute Intranasal Aerosol Dose of PH94B on Social and Performance Anxiety in Women With Social Anxiety Disorder
- (2014) Michael R. Liebowitz et al. AMERICAN JOURNAL OF PSYCHIATRY
- Gaseous nitric oxide reduces influenza infectivity in vitro
- (2013) Gilly Regev-Shoshani et al. NITRIC OXIDE-BIOLOGY AND CHEMISTRY
- Role of the Spike Glycoprotein of Human Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Virus Entry and Syncytia Formation
- (2013) Zhaohui Qian et al. PLoS One
- A phase I clinical study of inhaled nitric oxide in healthy adults
- (2012) Chris Miller et al. Journal of Cystic Fibrosis
- Protection from the acquisition of Staphylococcus aureus nasal carriage by cross-reactive antibody to a pneumococcal dehydrogenase
- (2012) R. S. Lijek et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Function of Mucosa-Associated Lymphoid Tissue in Antibody Formation
- (2010) Per Brandtzaeg IMMUNOLOGICAL INVESTIGATIONS
- Nasal vaccine innovation
- (2010) Inderjit Jabbal-Gill JOURNAL OF DRUG TARGETING
- Dual effect of nitric oxide on SARS-CoV replication: Viral RNA production and palmitoylation of the S protein are affected
- (2009) Sara Åkerström et al. VIROLOGY
- Nanotechnology in vaccine delivery
- (2008) Laura J. Peek et al. ADVANCED DRUG DELIVERY REVIEWS
- Cathepsin L Functionally Cleaves the Severe Acute Respiratory Syndrome Coronavirus Class I Fusion Protein Upstream of Rather than Adjacent to the Fusion Peptide
- (2008) B. J. Bosch et al. JOURNAL OF VIROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started